Cargando…
Citrullinated and malondialdehyde-acetaldehyde modified fibrinogen activates macrophages and promotes an aggressive synovial fibroblast phenotype in patients with rheumatoid arthritis
OBJECTIVE: Post-translational protein modifications with malondialdehyde-acetaldehyde (MAA) and citrulline (CIT) are implicated in the pathogenesis of rheumatoid arthritis (RA). Although precise mechanisms have not been elucidated, macrophage-fibroblast interactions have been proposed to play a cent...
Autores principales: | Aripova, Nozima, Duryee, Michael J., England, Bryant R., Hunter, Carlos D., Mordeson, Jack E., Ryan, Evan M., Daubach, Eric C., Romberger, Debra J., Thiele, Geoffrey M., Mikuls, Ted R. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10467288/ https://www.ncbi.nlm.nih.gov/pubmed/37654483 http://dx.doi.org/10.3389/fimmu.2023.1203548 |
Ejemplares similares
-
Unique Antibody Responses to Malondialdehyde-Acetaldehyde (MAA)-Protein Adducts Predict Coronary Artery Disease
por: Anderson, Daniel R., et al.
Publicado: (2014) -
Direct antioxidant properties of methotrexate: Inhibition of malondialdehyde-acetaldehyde-protein adduct formation and superoxide scavenging
por: Zimmerman, Matthew C., et al.
Publicado: (2017) -
Serum anti-malondialdehyde-acetaldehyde IgA antibody concentration improves prediction of coronary atherosclerosis beyond traditional risk factors in patients with rheumatoid arthritis
por: Lomzenski, Hannah E., et al.
Publicado: (2022) -
Malondialdehyde-Acetaldehyde Modified (MAA) Proteins Differentially Effect the Inflammatory Response in Macrophage, Endothelial Cells and Animal Models of Cardiovascular Disease
por: Duryee, Michael J., et al.
Publicado: (2021) -
Malondialdehyde-acetaldehyde (MAA) modified proteins induce pro-inflammatory and pro-fibrotic responses by liver endothelial cells
por: Thiele, Geoffrey M, et al.
Publicado: (2004)